Category Specific RSS

News

Rising death rates Propel demand for funeral services

Despite the awkwardness of a pandemic with death being talked about more than ever, Propel Funeral Partners (ASX: PFP) have been diligently handling the sensitivity of increasing death rates which has resulted in greater demand for funeral services.

For the Quarter ended 30 September 2021, Propel has reported a 13% increase in revenue compared to the previous corresponding quarter which was driven by a 10% increase in total funeral volume over the same period.

“Propel’s diversified network of funeral and related social infrastructure assets across Australia and in New Zealand has continued to deliver considerable financial resilience in the first quarter of FY22, despite COVID-19 impacts, and I thank our staff for their dedication to providing essential funeral and related services to local communities,” said Propel Managing Director, Albin Kurti.

“Hopefully extended lock downs, strict funeral attendee limits and travel restrictions will soon be behind us, enabling bereaved client families to grieve in a manner that they ordinarily would, surrounded by family and friends.”

While funerals in locked down States have been impacted by attendance limits, this has not impacted Propel’s operating EBITDA margins which were maintained at 28%, only slightly down on the 30% achieved across FY21.

Having reported $120.4m in revenue for FY21 with operating net profit after tax up 7.6% to $15.3m for the year, Propel has signalled their intent to expand via acquisitions.

Operating a mix of different brands in the fragmented funeral home industry, Propel is the second largest funeral service provider in Australia and New Zealand with 136 locations that includes 9 cemeteries.

Aging populations are expected to contribute to rising demand for Propel in its core markets where death volumes in Australia are expected to increase by 2.7% annually from 2019 to 2030 and 2% in New Zealand.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago